by Five Rivers Rx | Oct 22, 2020 | Industry News, Uncategorized
The Maryland Board of Pharmacy became the 4th state to accept NCDQS QAS Accreditation or Inspection program as part of their licensing requirement as of their October 21, 2020 meeting. Maryland The Maryland Board of Pharmacy has required out-of-state applicants to...
by Five Rivers Rx | Oct 7, 2020 | NABP
NABP has released a new version of its Policy and Procedure Assessment for Drug Distributor Accreditation. We analyzed the 4 removed standards and provide insight on the 10 new/revised standards. Background: Policies and Procedures (P&P) are the true backbone of...
by Five Rivers Rx | Oct 7, 2020 | Five Rivers
Penn Valley, PA Release: October 7, 2020. For Immediate Release Five Rivers RX announced its 5th anniversary as a pharmaceutical supply chain consulting and administrative company. Five Rivers RX was founded by Sumeet Singh with a vision to promote the integrity of...
by Five Rivers Rx | Sep 23, 2020 | Industry News
The pharmaceutical supply chain industry is now funding New York’s efforts to combat the opioid crisis through two separate mechanisms. Originally New York state legislature passed the Opioid Stewardship Act (OSA) that was designed to collect $100 million per year for...
by Five Rivers Rx | Sep 10, 2020 | DEA, Suspicious Order Monitoring
Public interest in the Opioid Epidemic has taken a back seat to this year’s events (COVID-19 pandemic, civil unrest, raging wildfires, elections), but new developments on suspicious order monitoring are expected to continue. Recent Developments In the last two...
